DiaMedica Therapeutics (DMAC) Operating Expenses (2018 - 2026)
DiaMedica Therapeutics (DMAC) posted quarterly Operating Expenses of $10.5 million for Q1 2026, up 28.71% year-over-year from $8.1 million in Q1 2025, and up 13.77% quarter-over-quarter from $9.2 million in Q4 2025.
DiaMedica Therapeutics (DMAC) Operating Expenses (2018 - 2026) Analysis & Trends
DiaMedica Therapeutics' Operating Expenses history runs 9 years deep, the most recent figure standing at $10.5 million for Q1 2026.
- In Q1 2026, Operating Expenses rose 28.71% year-over-year to $10.5 million; the TTM figure through Mar 2026 stood at $36.7 million (up 26.31% YoY), while the FY2025 annual figure was $34.4 million, up 28.92% from the prior year.
- Operating Expenses for Q1 2026 stood at $10.5 million, up from $9.2 million in the prior quarter.
- The five-year high for Operating Expenses was $10.5 million in Q1 2026, with the low at $3.1 million in Q3 2022.
- The 5-year median for Operating Expenses is $5.7 million (2024), against an average of $6.3 million.
- The sharpest annual moves came in 2022 and 2023: Operating Expenses declined 8.43% in 2022, then jumped 64.87% in 2023.
- DiaMedica Therapeutics' Operating Expenses stood at $4.0 million in 2022, then jumped by 47.19% to $5.8 million in 2023, then soared by 43.96% to $8.4 million in 2024, then rose by 9.43% to $9.2 million in 2025, then grew by 13.77% to $10.5 million in 2026.
- Business Quant data shows DMAC's Operating Expenses at $10.5 million in Q1 2026, $9.2 million in Q4 2025, and $9.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | DiaMedica Therapeutics | 360.22 Mn | 360.22 Mn | - | 10.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.50 Mn |
| Mar 31, 2026 | 10.48 Mn |
| Dec 31, 2025 | 9.21 Mn |
| Sep 30, 2025 | 9.03 Mn |
| Jun 30, 2025 | 8.01 Mn |
| Mar 31, 2025 | 8.14 Mn |
| Dec 31, 2024 | 8.42 Mn |
| Sep 30, 2024 | 6.88 Mn |
| Jun 30, 2024 | 5.64 Mn |
| Mar 31, 2024 | 5.74 Mn |
| Dec 31, 2023 | 5.85 Mn |
| Sep 30, 2023 | 5.16 Mn |
| Jun 30, 2023 | 4.74 Mn |
| Mar 31, 2023 | 5.52 Mn |
| Dec 31, 2022 | 3.97 Mn |
| Sep 30, 2022 | 3.13 Mn |
| Jun 30, 2022 | 3.36 Mn |
| Mar 31, 2022 | 3.54 Mn |
| Dec 31, 2021 | 3.25 Mn |
| Sep 30, 2021 | 3.42 Mn |